Author

Arushi Bamrara

Observed names: A Bamrara, A. Bamrara

Institution: Novartis (India)

Observed institutions: Novartis (India), PAREXEL International (India)

ORCID: 0000-0003-4208-409X

Observed ORCID: 0000-0003-4208-409X

OpenAlex ID: A5035685060

Bilosomes: A Novel Approach to Meet the Challenges in Oral Immunization

2015 · Meenakshi Chauhan, Parbat Sahoo, et al. · Recent Patents on Drug Delivery & Formulation · 14

Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons

2020 · John R Hurst, Kevin Gruffydd-Jones, et al. · International Journal of COPD · 12

Simultaneous estimation of gliclazide and lacidipine using spectrophotometric methods and its application in nanostructured lipid carrier (NLC) development

2014 · Meenakshi Kanwar Chauhan, Parvat K Sahoo, et al. · Der pharmacia lettre · 2

Pb2012: Describing Treatment Patterns in Patients With Myelodysplastic Syndrome According to Ipss-r Risk Category

2023 · Sorcha Corry, Arushi Bamrara, et al. · HemaSphere

Pcn359 Value Assessment of Hta Decisions for Pd-1/pd-l1 Inhibitors in Oncology: a Nice Perspective

2019 · A. Bamrara, N. Mishra, et al. · Value in Health

Value Communication Strategies for Immunotherapies in Nsclc: A Quick Evidence Assessment from The UK

2017 · S Kamra, M Sehgal, et al. · Value in Health

Works count: 6

Citation count: 28

H-index: 2

I10-index: 2